Clinical Trial Update: A Clinical Study to Evaluate SM17 in Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating SM17 in healthy participants has completed. The study lists Atopic Dermatitis, Asthma, and Inflammatory Bowel Disease among its associa…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma
• Atopic Dermatitis
• Inflammatory Bowel Disease

Drugs mentioned

• SM17

Snippet

Sponsor: SinoMab BioScience Ltd | Conditions: Atopic Dermatitis, Asthma | Phase 1 | Status: COMPLETED